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Background: Oct4 is a transcription factor that plays a major role for the preservation of the pluripotent state in
embryonic stem cells as well as for efficient reprogramming of somatic cells to induced pluripotent stem cells
(iPSC) or other progenitors. Protein-based reprogramming methods mainly rely on the addition of a fused cell
penetrating peptide. This study describes that Oct4 inherently carries a protein transduction domain, which can
translocate into human and mouse cells.
Results: A 16 amino acid peptide representing the third helix of the human Oct4 homeodomain, referred to as Oct4
protein transduction domain (Oct4-PTD), can internalize in mammalian cells upon conjugation to a fluorescence moiety
thereby acting as a cell penetrating peptide (CPP). The cellular distribution of Oct4-PTD shows diffuse cytosolic and nuclear
staining, whereas penetratin is strictly localized to a punctuate pattern in the cytoplasm. By using a Cre/loxP-based reporter
system, we show that this peptide also drives translocation of a functionally active Oct4-PTD-Cre-fusion protein. We further
provide evidence for translocation of full length Oct4 into human and mouse cell lines without the addition of any kind of
cationic fusion tag. Finally, physico-chemical properties of the novel CPP are characterized, showing that in contrast to
penetratin a helical structure of Oct4-PTD is only observed if the FITC label is present on the N-terminus of the peptide.
Conclusions: Oct4 is a key transcription factor in stem cell research and cellular reprogramming. Since it has been
shown that recombinant Oct4 fused to a cationic fusion tag can drive generation of iPSCs, our finding might
contribute to further development of protein-based methods to generate iPSCs.
Moreover, our data support the idea that transcription factors might be part of an alternative paracrine signalling
pathway, where the proteins are transferred to neighbouring cells thereby actively changing the behaviour of the
recipient cell.
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ReprogrammingIntroduction
Cell penetrating peptides (CPPs) - also known as protein
transduction domains (PTDs) - are an intensively studied,
yet diverse class of peptides in regard to amino acid com-
position, size, charge and structure. Their joint feature is
the mediation of the internalization of a peptide or a pro-
tein and, in most cases, a conjugated cargo. Classifications
are either based on the physico-chemical nature of the* Correspondence: johannes.grillari@boku.ac.at
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stated.sequence (primary-, secondary-, or non-amphiphatic) [1]
or their origin (protein-derived, chimeric or synthetic
peptides) [2].
The first CPPs, Tat and penetratin, were described al-
ready in the late 1980s and early 1990s, and are still among
the most studied CPPs today [3]. Tat is derived from amino
acids 48-60 of HIV-1 trans-activator of the transcription
(Tat) protein [4,5], while penetratin derives from the Dros-
ophila melanogaster homeodomain protein Antennapedia
(Antp). Antp is a transcription factor and its 60 aa homeo-
domain (pAntp) can be unconventionally secreted without
the need of a signal peptide [6]. Consequently, it can beral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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way [7]. Penetratin, a 16 amino acid peptide, corresponds
to the third helix of the Antp homeodomain and has been
shown to be sufficient for uptake of the whole protein [8].
In previous studies it was shown that internalization of
penetratin relies mainly on endocytosis [9], but direct
translocation has also been proposed [10-12]. Still, the
mechanism of uptake remains debatable [3].
Detailed characterization of the mechanisms guiding pep-
tide internalization is desired, and i.e. the interaction of
penetratin and its derivatives with cellular membrans has
been intesively studied using lipid model systems [13]. These
studies have clarified that upon binding of penetratin to an-
ionic lipid membranes, the peptide changes its secondary
structure and adopts either an α-helical or β-sheet shaped
structure, depending on the peptide/lipid ratio [14,15].
Ever since the discovery of penetratin, a number of
other peptides as well as proteins from the large family
of homeodomain transcriptional regulators have been
assessed for their capacity to cross cellular membranes.
Prominent examples of internalized whole proteins or
the homeodomain helix in combination with cargo mol-
ecules are Hoxa5, Hoxc8, PDX-1 or Engrailed-2 [16-19].
However, not all homeodomain peptides or proteins are
efficiently taken up by cells [20]. In contrast, uptake of
Pax-4, a paired-box transcription factor also containing
a homeodomain, has been shown to depend upon the
paired domain rather than the homeodomain [21].
One homeodomain protein that previously has not
been tested for containing a functional PTD is human
Oct4. Oct4 is a prominent member of the POU-family
of transcription factors containing two distinct DNA-
binding domains, the POU-specific domain and the
homeodomain [22]. It is necessary for maintaining the
pluripotent state of embryonic stem cells [23], but has
probably raised most interest as a key factor for cellular
reprogramming of somatic cells into induced pluripotent
stem cells (iPS) [24].
While several techniques to non-integratively transfect
cells with reprogramming factors like mRNA or CPP-
tagged proteins [25-29] have been reported, a simple
and safe approach adding no genetically altered authen-
tic recombinant protein has not been tested so far.
Therefore, we explored if the third helix of the human
Oct4 homeodomain (Oct4-PTD) might in principle be
able to translocate into living cells and mediate cargo
uptake. We compared this activity as well as its second-
ary structure, membrane interaction and cytotoxicity to
the well characterized CPP penetratin.
We report that Oct4-PTD-mediated uptake is very ef-
ficient, and that already 1 hour after exposure, FITC-
labelled Oct4-PTD localizes to the nucleus and diffusely
to the cytoplasm. Structural analysis of the peptides
using circular dichroism (CD) showed that upon bindingto large unilamellar vesicles (LUVs), a helical structure
of Oct4-PTD is only observed if the FITC label was
present on the N-terminus of the peptide. In contrast,
penetratin shows a helical structure independently of the
fluorescence moiety.
Moreover, we show that recombinantly expressed and
purified Oct4-PTD-Cre fusion protein successfully trans-
locates into reporter cells when added to the medium
and recombines loxP-modified marker genes. Finally, a
weak but significant uptake of recombinantly expressed
native human Oct4 was observed. We therefore suggest
that uptake of Oct4 might be a further contribution to-
wards establishing safe methods to generate iPSCs.
Material and methods
Materials
Peptides (>95% purity) were purchased from Biomatik
(Cambridge, Ontario, Canada). For labelled peptides the
N-terminal fluorescein isothiocyanate (FITC) label was
conjugated by an Acp (amino caproic acid) linker. The
peptides were delivered as lyophilized acetate salts, dis-
solved in MQ-water and stored at -20°C as aliquots. Cell
culture media were from PAA Laboratories and Biochrom
AG (Berlin, Germany), heparin sodium was purchased
from Serva (Heidelberg, Germany) and buffer salts were
from Sigma. FM 4-64 dye and 7-aminoactinomycin D
(7-AAD) were from Invitrogen. 1-Palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), 1-Palimitoyl-2-oleoyl-
sn-glycero-3-phosphoglycerol (POPG) were from Larodan
Fine Chemicals (Malmö, Sweden).
Cell culture
Chinese Hamster Ovary cells (CHO-K1) were cultured
in Ham’s F12 medium supplemented with 10% fetal calf
serum and 2 mM L-Glutamine. RPTEC/TERT1 cells
[30] were cultivated in ProxUp medium (Evercyte GmbH,
Austria). CV1-5B cells and BJ foreskin fibrobrasts were
cultured in DMEM supplemented with 10% FCS, 1×
NEAA, 1× Sod.-Pyruvat (all Life technologies, Carlsbad,
CA). Cell lines were maintained under antibiotic free con-
ditions at 37°C and 5% CO2.
Flow cytometry
For quantitative analysis of uptake 10,000 CHO-K1 cells
were seeded per well of a 96-well plate 48 h prior to the
experiment and cultured to approximately 80% conflu-
ence. The cells were washed with serum-free (SF) Ham’s
F12 and subsequently incubated with indicated concen-
trations of FITC-labelled peptides diluted in SF-medium
for 60 min at 37°C, 5% CO2.
Following incubation cells were washed twice with
20 mM HEPES/150 mM NaCl, pH 7.4, supplemented
with 100 μg/ml Heparin in the first wash step to remove
membrane bound peptide from the cell surface [31].
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mediately analyzed using a Guava EasyCyte 8HT flow
cytometer (Millipore). For every concentration step, 4
individual wells were seeded and analyzed (n = 4) and
experiments were repeated at 3-4 separate occasions
(N = 3-4). Untreated cells were used to set the gate on
live cells (FSC/SSC) and fluorescence emission of 5000
cells was recorded through a 525/30 nm filter. Uptake
data are reported as mean fluorescence intensity (MFI)
of all gated cells in each sample. For statistical analysis
of significance Student’s t-tests were performed.
Cell proliferation using MTT
The MTT assay is based on the detection of the reduction
of yellow MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide) to purple formazan which can be
detected photometrically at 530 nm [32]. RPTEC/TERT1
cells were seeded in 96-well plates and cultured to 90%
confluence. Cells were incubated in triplicates with 0;
1.25; 2.5; 5.0;10.0; 20.0; 40.0; and 80 μM of unlabelled pep-
tide and incubated for 1 h or 24 h in serum free medium
at 37°C, 5% CO2. The mean value of each concentration
point was compared with the negative control. Endpoints
of the measurements were plotted and a 1-way ANOVA
was calculated using Friedmann Test in GraphPad Prism.
Haemolysis
For testing the haemolytic activity of both labelled and un-
labelled peptides, fresh human red blood cells (RBCs) were
isolated from whole blood using a Ficoll gradient. The cells
were washed twice in PBS and were subsequently resus-
pended in PBS to gain a final concentration of 4% (v/v).
100 μl of RBCs were substituted with 100 μl of the respect-
ive peptide solution diluted in PBS to gain a final peptide
concentration of 5, 15 or 45 μM, followed by incubation at
37°C for 1 h. As negative control, RBCs were incubated in
PBS and as positive control, corresponding to 100%
hemolysis, cells were incubated with 0.05% Triton-X100 in
PBS. Cells, treated with FITC-labelled peptides were
blanked against a dilution of respective peptide in PBS and
an absorbance scan of the FITC spectrum (in PBS) con-
firmed no peak at 405 nm. All samples were analyzed in
three biological replicates. Absorbance was detected at
405 nm on a Tecan Infinite 200 PRO Microplate Reader
and hemolytic activity was calculated following [33].
% hemolysis ¼ 100 Asample−Ablank
 
= Atriton−Ablankð Þ
 
Confocal imaging
For confocal live cell imaging CHO-K1 cells were seeded
at a density of ~14,000 cells/cm2 in round glass bot-
tomed dishes 48 h prior to microscopy. For imaging,
cells were rinsed with SF-medium and incubated with
FITC-labelled peptides at indicated time points (15, 3060 min) and concentrations (5 or 10 μM) in the pres-
ence or absence of 5 μg/ml FM 4-64 dye at 37°C or 4°C.
Microscopy was performed on a Leica TCS SP confocal
system equipped with a HCX PL APO CS 63× objective.
For excitation of FITC the 488 nm laser line of an Ar
laser was used and the 543 nm laser of a He/Ne laser
was used for excitation of FM 4-64. Sequential scanning
mode was used to avoid bleed through between the
channels; laser and photomultiplier settings were kept
constant within each experiment. Image optimization of
contrast, gain and brightness was performed to the same
extent within each experiment and intensities of the re-
spective panels are therefore comparable.
Preparation of LUVs
Large unilamellar vesicles (LUVs) were prepared by ex-
trusion as previously described [34]. In brief, a solution
of POPC/POPG (80/20 molar ratio) dissolved in chloro-
form was mixed in a round bottom flask, after which the
solvent was completely evaporated. Vesicles were formed
by dispersion of the lipid film in 10 mM NaPO4 buffer,
pH 7.4 under vortexing (5 min), followed by five freeze-
thaw cycles (liquid nitrogen/50°C) and extruding 21
times through Nucleopore polycarbonate filters with a
pore diameter of 100 nm using a LiposoFast-Pneumatic
extruder (Avestin, Canada). LUVs used for LD studies
were prepared in the same phosphate buffer described
above containing 50% (w/w) sucrose.
Circular dichroism (CD) spectroscopy
Circular dichroism (CD) spectroscopy was performed
using a Chirascan instrument (Applied Photophysics,
Leatherhead, UK). The instrument was flushed with nitro-
gen at a flow rate of 5 l/min. Far-UV CD spectra were re-
corded in the region between 185 nm and 270 nm, the path
length was 2 mm, 1 nm steps were performed at a band-
width of 2 nm and the scan time per point was set to 0.5 s.
20 repeats were averaged for each sample and baseline-
correction was performed by subtracting appropriate
blanks. The experiments were repeated at three different
occasions. 4 μM of peptide solution was measured in the
absence or presence of 0.4 mM LUVs (peptide:lipid-ratio
1:100) in 10 mM NaPO4 buffer, pH 7.4. Since the signal of
unlabelled Oct4-PTD in this concentration was very week,
an additional measurement with 12 μM unlabelled Oct4-
PTD was performed, with a peptide to lipid ration of 1:33.
Linear dichroism (LD) spectroscopy
Linear dichroism (LD) is the difference in absorption be-
tween linearly polarized light parallel (A||) and perpen-
dicular A⊥ to an orientation axis [35].
LD ¼ Ajj−A⊥
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larimeter (Applied Photophysics, Leatherhead, UK)
equipped with a Couette flow cell. The flow cell consists
of two cylinders and the applied sample was aligned in
the gap between them resulting in an optical path length
of 1 mm. Spectra were measured between 185 nm and
600 nm at a shear flow of 3100 s-1. The spectra were
baseline corrected by subtracting the corresponding
spectrum without rotation [36]. 14 μM of unlabelled
peptide was added to 1.4 mM LUVs in a 10 mM
phosphate buffer (pH 7.4). The buffer contained 50%
(w/w) sucrose to reduce light scattering and improve the
macroscopic orientation [37]. Reduced LD (LDr), which is
a concentration and pathlength-independent quantity, was
obtained by dividing the LD with the isotropic absorption
(Aiso). Aiso was recorded for each sample on a Varian Cary
Bio 50 (Agilent Technologies, USA) spectrophotometer,
between 185 nm and 600 nm, directly after the flow LD
measurement.
Construction of expression plasmids
Chemically synthesized oligonucleotides used in the
cloning steps are listed in Additional file 1: Table S1.
Human Oct4-PTD (wild-type) and mutants thereof
(R16A and K13A/R16A), were cloned into a 6His-Cre
fusion protein expressing construct [38], in two steps.
First, sense and antisense oligonucleotides were annealed
in fusion polymerase buffer (1X) (New England Biolabs,
Inc.) by heating to 95°C for 5 minutes and cooling at
room temperature for 15 minutes to generate a
double-stranded (ds) oligo. Second, the ds-oligo was
added to the N-terminus of the Cre fusion protein
expression construct as NcoI-PstI fragment to gener-
ate Oct4-PTD-His-Cre wild type and mutant expres-
sion constructs.
Purification of fusion proteins and translocation assays
Protein expression and purification of Oct4 protein and
fusions thereof was carried out as previously described
[28,39,40]. pSESAME-Oct4 vectors enable bacterial ex-
pression of histidine-tagged Oct4 fusion proteins carrying
the CPP derived from TAT. For expression, BL21 (DE3)
competent bacteria were transformed with pSESAME-
Oct4 plasmids and protein production was induced by
addition of Isopropyl-b-D-thiogalactopyranosid (IPTG;
Life technologies, Carlsbad, CA). The bacteria containing
recombinant protein were collected by centrifugation and
lysed using disruption buffer (100 mM Tris, 1 mM EDTA,
pH 8.0, 3 mM MgCl2) supplemented with 1 mg/ml lyso-
zyme (Fluka Analytical, St. Gallen, Switzerland) as well as
10 U/μl benzonase (Merck, Darmstadt, Germany). The
crude lysate was centrifuged and the pellets containing the
inclusion bodies were washed repeatedly with washing
buffer (50 mM Tris, 0.1 M NaCl, 0.5% Triton-X-100(Sigma, Saint Louis, MO), 0.1% sodium azid, pH 8.0 and
0.1 M Tris, 2 mM EDTA, pH 8.0). The inclusion body
fraction was solubilized using 8 M Urea, 50 mM Tris,
1 mM EDTA, 100 mM DTT and dialysed against a buffer
comprising 6 M GuaHCL (pH 4.5). In a next step, the
denatured protein was refolded by rapid dilution in
50 mM Na2HPO4, 1 mM EDTA, 5 mM GSG, 3 M
Urea, 20% Glycerol, 1 M L-Arginine and 5% sucrose.
The refolded protein was incubated with Ni-NTA
agarose beads (Qiagen, Hilden, Germany) and concen-
trated by affinity chromatography. The protein was
eluted with 50 mM Na2HPO4, 5 mM Tris, 500 mM
NaCl, 250 mM imidazole (pH 7.8). The purity of the
Oct4 protein was routinely controlled by SDS-PAGE
(Additional file 2: Figure S2).
For the Oct4 translocation assay recombinant human
Oct4 protein was dialyzed against protein transduction
media (DMEM/F12, 2% FCS, 7,5% Serum Replacement,
100 mM b-mercaptoethanol, 1× NEAA, 1× Insulin-
Transferrin-Selenium-Ethanolamine and 0.5% AlbuMAX.
All media and cell culture supplements were purchased
from Life technologies, Carlsbad, CA). Cultured CVI-5B
and BJ fibroblast cells were incubated with 100 nM re-
combinant Oct4 protein for 3 hours. After removal of the
protein transduction media cells were washed with PBS
three times. Thereafter a Heparin (Sigma H3149) wash
(0.5 mg/ml in PBS) was performed twice to remove
non-internalized protein bound to the surface. Subse-
quently, cells were fixed in 4% paraformaldehyde for
10 min, blocked with 1% BSA and 0.1% Triton X-100 in
PBS for 1.5 h and incubated with primary (anti-Oct-3/4,
Santa Cruz Biotechnology sc-5279, 1:100) for 1.5 h and
secondary antibody (Alexa 488) for 1 h. Nuclei were vi-
sualized by DAPI staining. Microscopy was done on a
Leica DM IL LED FLUO inverted microscope in 40×
and 63× magnification.
Functional assessment of internalized recombinant
Cre-fusion protein was performed using the CVI-5B Cre
reporter cell line as previously described [38].
Results
Oct4 contains a penetratin like CPP-domain
The cell penetrating peptide penetratin is derived from a
DNA binding domain of a homeobox transcription fac-
tor. Oct4 belongs to the same class of transcription fac-
tors and also contains a bi-partite DNA-binding domain,
the POU-specific domain (POUs), which recognises the
octamer motif as well as the homeodomain (POUhd)
(Figure 1A). Therefore, we aligned Oct4 and penetratin
sequences and found a high degree of homology in the
third helix of the respective homeodomains. The hom-
ology between the 16 aa of penetratin and the respective
region of Oct4 is 7 out of 16 (43%) identities and 11 of
16 (68%) similarities (Figure 1B). Due to this similarity
Figure 1 Overview of the investigated peptides. (A) Oct4-PTD derives from the third helix of the homeodomain (orange) of the transcription
factor Oct4 (POU5F1), which possesses a POU-specific and a homeodomain [42], pdb: 3L1P. (B) The sequence alignment of Oct4-PTD and Penetratin
shows great conservation, almost half of the residues are identical (*), more than two thirds of the peptide share at least same charge (* or :)
(C, D) Helical wheel projection of Oct4-PTD or penetratin.
Figure 2 Cellular uptake determined by flow cytometry. Cells
were incubated with 0, 2.5, 5, 10, 15 μM of FITC-labelled Oct4-PTD
(black, solid) or Penetratin (gray, dashed) for 60 min at 37°C, washed
with a heparin containing buffer to remove extracellular peptide and
analysed for uptake. The results represent the mean fluorescence
intensity (MFI) of 3 (15 μM) or 4 (2.5, 5, 10 μM) independent
experiments (N = 3-4) with 4 biological replicates per experiment
(n = 4). Compared to the untreated cells, both peptides show significant
uptake even at the lowest concentration. **p-value ≤ 0.001.
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domain (Oct4-PTD). The Oct4-PTD differs from pene-
tratin mainly by having less lysines but more arginines –
a feature that might be of advantage as far as uptake is
concerned [41]. These differences are visualized by a hel-
ical wheel projection showing the differing distribution
of the charges over the peptide suggesting diverging
structural features of Oct4-PTD compared to Penetratin.
Still, we considered the similarities to be sufficiently high
to test Oct4-PTD for a putative activity as CPP.
Oct4-PTD is taken up more efficiently than Penetratin by
CHO-K1 cells
In order to quantitatively compare uptake of Oct4-PTD
to the well studied penetratin, we performed flow cy-
tometry on N-terminally FITC labelled versions of the
peptides. Uptake was analysed after 60 min incubation
of CHO-K1 cells with different concentrations of pep-
tides at 37°C and stringent washing with Heparin to re-
move externally bound peptide as described previously
[31]. The cells efficiently took up both peptides in a con-
centration dependent manner (Figure 2). No saturation
was observed in the applied concentration range, which
varied from 2.5 μM to 15 μM. Relative quantification
showed that Oct4-PTD displayed higher uptake efficiency
than penetratin. This is visualised by subtracting the fluor-
escence values of penetratin from the ones of Oct4-PTD.
Thus, in the 60 min exposure that we used, linearlyincreasing amounts of Oct4-PTD over penetratin were
observed, reaching significance at 15 μM (Figure 2). Pep-
tide concentrations below 2.5 μM did not result in detect-
able uptake signals (data not shown), possibly a result of
the detection limit of our instrumentation.
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In order to visualize the cellular distribution of the la-
belled peptides, confocal live cell imaging was per-
formed. After 15 min of cellular exposure to the CPPs,
weak binding of both peptides to the plasma membrane
was observed. At this time point no peptide seemed to
be internalized, and in both cases a punctuate pattern at
the membrane could be observed (Figure 3A). After
30 min a strong increase in fluorescence signal was seen
(Figure 3B). Both peptides were not only bound to the
membrane but had entered the cells. Furthermore, punc-
tuate staining of the cytosol was observed for penetratin.
In contrast, the Oct4-PTD signal, even though in part
punctuate, appeared to be more diffuse in the cytoplasm
and, surprisingly, also to be present in the nuclei. After
60 min of incubation, this difference in localization was
even more pronounced. While most penetratin remained
trapped in punctuate patterns excluded from the nuclei,Figure 3 Time-dependent uptake and differences in localization patte
or (B) Penetratin for 15, 30 or 60 min at 37°C. Peptides were applied at a fi
photomultiplier settings were kept constant during the entire experiment;possibly representing endosomes, Oct4-PTD was found
throughout the cell (Figure 3).
Oct4-PTD does not show cytotoxic effects
Since the applicability of CPPs is dependent on low or
preferably absent toxic effects, we assessed cytotoxicity
of the peptides using two different approaches. In the
first approach, a telomerase-immortalized human adher-
ent renal cell line, that still retains all characteristics of
normal cells and has been widely used as a toxicity
model system [30,43], was exposed to the unlabelled
peptides. No effect on cell viability and proliferation was
detected with MTT for the tested peptides even at the
highest concentration applied (Additional file 3: Figure S3).
The second assay tested the hemolytic activity of both
peptides on human red blood cells. Here, both peptides
were applied either in their unlabelled or FTIC-labelled
form. Again, no cytotoxic influence of the unlabelledrn. Confocal images of live CHO-K1 cells incubated with (A) Oct4-PTD
nal concentration of 5 μM in serum free medium. Laser and
intensities are therefore comparable.
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labelled penetratin and labelled Oct4-PTD showed around
7% and around 2% hemolysis respectively at the highest
concentration (45 μM).
Oct4-PTD is at least partly internalized via endocytosis
Due to the striking differences in localization, we tested
whether the uptake is at least in part mediated by direct
translocation into the cells or if it rather relies on endo-
cytic pathways. Therefore, we co-incubated the cells
with peptide solutions and the general endocytosis
marker FM 4-64 at 4°C or 37°C for 60 min and moni-
tored the respective uptake behaviour using confocal mi-
croscopy. Since endocytosis is blocked at 4°C, no
internalization of newly formed endosomes should be
observed. Figure 4A shows that after 60 min of blocked
endocytosis, neither Oct4-PTD nor penetratin was inter-
nalized. The peptides remained stuck at the plasma
membrane and co-localized with extracellularly bound
FM 4-64 marker. Thus, we did not detect any direct
translocation of either peptide into the cells. At 37°C a
clear partial co-localization of both FM 4-64 and both
peptides can be seen (Figure 4B) indicating, at least in
part, endocytic transport of the peptides into the cells.
The alpha helical structure of Oct4-PTD is dependent
on FITC
CPPs can fold into distinct secondary structures, includ-
ing α-helixes and random coils, upon interaction with
lipid membranes. The resulting structures interact more
or less strongly with the plasma membrane, leading to
differences in uptake efficiency and cellular distribution
[14]. Therefore, circular dichroism (CD) was measured
to evaluate secondary structures of penetratin and Oct4-
PTD, with and without fluorophore, in buffer and whenTable 1 Hemolytic activity of FITC-labelled and unlabelled
peptides
Peptide Concentration [μM] % hemolysis
Oct4-PTD unlabelled 5 0
15 0
45 0.1
Oct-4PTD + FITC 5 0
15 0
45 2.0
Penetratin unlabelled 5 0
15 0
45 0
Penetratin + FITC 5 2.5
15 5.0
45 7.2bound to lipid vesicles. Both FITC-labelled peptides
show a random coil structure in buffer. When bound to
lipid vesicles, FITC-labelled penetratin and ditto Oct4-
PTD show an evident α-helical signal, with a positive
peak at 195 nm, and two negative peaks at 208 nm and
223 nm respectively (Figure 5A). If instead looking at
the unlabelled peptides (Figure 5B), penetratin adopts an
even more pronounced α-helix when bound to lipo-
somes and an evident random coil when free in solution.
However, the unlabeled Oct4-PTD shows an extremely
weak, seemingly absent CD signal, indicating an un-
ordered structure. The measurement was repeated with
a three times higher peptide concentration, still render-
ing a very weak signal. The results show that a fluores-
cent label may induce structural changes in peptides,
affecting the secondary structure of the peptide, both
when free in solution or bound to lipid membranes.
Peptide orientation upon binding to lipid model
membranes
The peptide backbone absorption in the far-UV can be
used to estimate the orientation of the peptide and its
moieties compared to the lipid membrane. As seen in
Figure 5C the LD signal for unlabeled penetratin is
much more pronounced than for unlabeled Oct4-PTD,
both regarding the tryptophan- and the α-helical transi-
tion moments. In an α-helix, the π-π* transition mo-
ments of neighbouring peptide bonds will split into two
transition moments, rendering one parallel to the helix
(200-210 nm) and one perpendicular to the helix
(<200 nm). The indole ring of tryptophan has three tran-
sition moments, Bb at around 225 nm, La at around
270 nm and Lb at around 290 nm [44]. The positive peek
at around 208 nm for penetratin points at this peptide be-
ing an α-helix, situated parallel to the membrane. At the
same wavelength Oct4-PTD shows a signal very close to
zero, meaning that this peptide does not form an α-helical
structure, in accordance with the CD-measurement of un-
labelled Oct4-PTD (see Figure 5B). Also the tryptophan
transition moments point to this result. For Oct4-PTD
the signal is overall very weak. Penetratin shows peaks for
Bb at 225 nm and for the overlapping peaks of La and Lb
between 230 and 300 nm, indicating that the secondary
structure of penetratin has a higher degree of order com-
pared to Oct4-PTD. The weak signal of Oct4-PTD also
makes it difficult to evaluate its relative orientation com-
pared with the membrane. The concentration and path
length-independent reduced LD (LDr) is presented in
Supplementary Information (Additional File 4: Figure S1).
Oct4-PTD drives translocation of fused proteins
In order to test if Oct4-PTD is able to translocate other
cargo than fluorescent labels into a cell and determine
their intracellular activity after transduction, we used a
Figure 4 Internalization is temperature-dependent and uses endocytic routes. Confocal images of live CHO-K1 cells after incubation in the
presence of the general endocytosis marker FM4-64 (red channel). Cells were incubated at (A) 4°C with 10 μM peptides or (B) 37°C using 5 μM
(green channel), concentration of FM4-64 was 5 μg/ml in both cases. Laser and photomultiplier settings were kept constant for each temperature;
intensities within the respective panels are therefore comparable.
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binant Oct4-PTD-Cre fusion protein as well as muta-
tions in the Oct4-PTD as controls. The design of the
mutants was based on a structure-activity relationship
study of penetratin that led us to perform a R16A and a
K13A/R16A exchange [46]. TAT-Cre, comprising the
highly potent TAT transduction peptide in fusion withCre served as a positive control [47]. After application of
purified fusion proteins to CVI-5B reporter cells we ob-
served a dose dependent activation of the loxP-modified
reporter gene indicating Cre uptake via the Oct4-PTD
(Figure 6A, B). Quantification of b-gal activity showed
that the two Oct4-PTD mutatnts inverstigated did not
result in b-gal activity above untagged Cre as observed
Figure 5 Conformational changes upon binding to LUVs.
Circular dichroism spectra of 4 μM (A) FITC-labelled and (B) unlabelled
Oct4-PTD (gray) and penetratin (black). Solid lines represent peptides in
the presence of 0.4 mM POPG/POPC (80/20) LUVs, dotted lines show
free peptide in solution. Measurements were performed in 10 mM
phosphate buffer, pH 7.4. (C) LD spectra of penetratin (gray) and
Oct4-PTD (black). Unlabelled peptides are represented as solid lines,
FITC-labelled peptides as dashed lines.
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PTD-Cre constructs were less efficient than the TAT-
tagged Cre control.
Oct4 translocates without the need of a cationic fusion tag
To test the ability of full length human Oct4 to enter
mammalian cells, we generated recombinant humanOct4 without additional transduction tag. Recombinant
Oct4 was administered to CVI-5B cells (Figure 6C) de-
scribed above but also to human BJ foreskin fibroblasts
(Figure 6E). After 3 hours incubation and a subsequent
heparin wash to remove membrane bound protein, Oct4
protein was detected by immunostaining in both cell
types (Figure 6C, E). Oct4 was particularly located in
punctuate, perinuclear vesicle-like structures. This char-
acteristic pattern has been widely described for trans-
duced proteins and indicates efficient cellular uptake
[48,49]. Figure 6D, F show the respective negative con-
trols, which were not exposed to recombinant Oct4
protein.
Discussion
The present study reports the identification and charac-
terization of a novel CPP derived from the homeodomain
protein Oct4. The corresponding peptide Oct4-PTD, was
found to be more efficiently taken up by cells than the well
known CPP penetratin. In addition, not only uptake effi-
ciency, but also intracellular localization varies between
Oct4-PTD and penetratin. After 15 min of incubation,
both peptides were bound to the plasma membrane in
vesicular structures but did not enter the cells. 15 minutes
later, the vesicular structures were for both peptides effi-
ciently internalized. After 60 min, Oct4-PTD clearly
showed diffuse staining within the whole cytoplasm as
well as the nucleus, while penetratin still localized exclu-
sively to cytoplasmic vesicles, excluded from the nucleus.
The observed differences in uptake and intracellular
localization might be associated with the higher number
of arginine residues in Oct4-PTD. Even though Oct4-PTD
has one cationic charge less than penetratin due to its N-
terminal aspartate, the arginine-rich C-terminal part of
the peptide still seems to have positive impact on the up-
take as previously reported for penetratin [46]. Especially,
the guanidinium head group of arginine has been shown
to confer more efficient uptake of arginine, possibly
caused by formation of bidentite hydrogen bonds with
oxo-anions from e.g. sulfated sugars present in the extra-
cellular matrix [50,51]. Predominant cyotosolic and nu-
clear staining has been observed before with other CPPs
or CPP-containing proteins in different cell lines [52-54].
Also, for lactoferrin-derived CPPs conjugated to Biotin-
Streptavidin, nuclear localization in live cells was depen-
dent on concentration of the peptide-cargo complex as
well as the origin, since only peptide derived from human
but not rat lactoferrin was detected in the nuclei [52]. Fur-
ther, PDX-1, a pancreatic homeobox factor has been
shown to be taken up by different target cell types and be
transported to the nucleus (Koya 2008, Noguchi 2005).
Therefore, testing the internalization ability and functional
activity of the whole Oct4 protein in various cell types was
a consequent step.
Figure 6 (See legend on next page.)
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Figure 6 Oct4-PTD is able to mediate uptake of protein cargo. (A) Oct4-PTD-Cre fusion proteins are taken up by CV1-5B Cre reporter cells as
determined by microscopy of cells stained positive for b-Gal activity. Increasing protein concentrations of recombinant wild type Oct4-PTD-Cre
fusion protein (WT) and mutated versions of the Oct4-PTD (R16A as wells as K13A/R16A) in fusion with Cre, respectively, were subjected to a Cre
recombinase assay where the intracellular activity of transduced protein is assessed by b-galactosidase activity [45]. TAT-modified Cre protein [47]
and unmodified Cre protein carrying no transduction peptide served as controls (first two rows). Quantification of Cre-reporter assay outlined in
(B) (n = 5). All values relative to TAT-Cre 1 μM. Error bars and n represent standard deviations and image sections quantified for b-Gal activity,
respectively. Two-tailed t-test was used for statistical analysis. *p <0.05, **p <0.01, ***p < 0.001. (C-F) Detection of recombinant human Oct4
protein in mammalian cells after extracellular exposure. CV1-5B (C) and human BJ foreskin fibroblasts (E) were incubated with 100 nM recombinant
human Oct4 protein for 3 hours, washed and subsequently stained for Oct4 and DAPI. (D, F) Untreated CV1-5B cells (D) and BJ fibroblasts (F) stained
with first (anti-Oct3/4) and secondary antibody (Alexa 488) served as controls. Scale bar: 25 μm.
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conserved, inherent protein transduction domains might
well be a more general phenomenon for these transcrip-
tion factors. Therefore, we have performed further se-
quence analysis and alignments (Figure 7) for the 3rd
helix of the homeodomain of other members of the
POU family of transcription factors (Oct1, Oct6 and Pit1).
We also included the aforementioned previously described
homeodomain-derived CPPs (Engrailed2, Hoxa5, Hoxc8).
As expected, Figure 7A shows that these sequences are
highly homologous. Still, there are some considerable dif-
ferences in the C-terminal region of the peptides. Espe-
cially at position 14 the variation between charges and
hydrophilic nature of the amino acid residues are evident
(Figure 7B). This makes it difficult to predict a potential
uptake of other homeodomain proteins.
How might the more efficient uptake and distribution
into cytoplasm and even nucleus be explained whenFigure 7 Conservation of the 3rd helix of selected homeodomain
transcription factors. Comparison of the 3rd helix of the homeodomain
three transcription factors with known crystal structures (Oct1, Oct6
and Pit1) as well as three previously published CPPs. (A) Sequence
alignments have been performed using T-coffee [55,56], (B) weblogo
illustrations were generated using weblogo 3.3 [57].looking at the sequence and the secondary structure of
the peptides? When bound to lipid membranes, both la-
belled Oct4-PTD and penetratin adopt α-helical confor-
mations, and for the unlabelled peptide the signal is
evidently more pronounced than for penetratin. This dif-
ference becomes even more evident with the LD mea-
surements, showing both higher degree of orientation
and a more prominent α-helical signal for penetratin.
One reason for the higher orientation monitored for
penetratin could be that this peptide has two trypto-
phans, whereas Oct4-PTD has one. Also, the position of
tryptophan and other hydrophobic, bulky residues could
have impact. When comparing the LD results with the
helical projection (Figure 1C), it is seen that there is an ac-
cumulation of hydrophobic residues on one side of pene-
tratin, compared with the more dispersed pattern for
Oct4-PTD, which could result in higher degree of orienta-
tion. Even if it still remains unclear what the role of a more
ordered structure in regard to uptake would be, it is clear
that the two peptides interact differently with membranes,
which might affect the uptake into cells. The relative im-
portance of the secondary structure for uptake is to date
not fully understood [58]. The lactoferrin derived CPP up-
take seems to strictly depend upon an α-helical conform-
ation [52] whereas Tat enters in a coiled conformation
[58]. Different helix-disruptive mutations of penetratin
showed similar uptake efficiencies as the wild type peptide
[59] while the more helical PenArg peptide had less effi-
cient uptake [60]. It is therefore very likely that the less or-
dered unlabelled Oct4-PTD is internalized and may be a
good vector for cargo molecules, although, we do at the
moment not know whether the FITC induced structural
difference will have impact on the uptake of Oct4-PTD. In
any case, it was surprising to see such a large impact on
the conformation of the Oct4-PTD by the FITC label, and
that for any experiment performed on CPPs, structural
analysis by CD may be an important tool to guarantee
comparability of data from studies using labelled and un-
labelled peptides for different types of analyses.
To understand if Oct4-PTD is directly translocated
through the membrane or if it is taken up by an endocy-
tic mechanism, co-localization studies with the general
endocytosis marker FM4-64 were performed at 4°C and
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either peptide was observed suggesting no direct trans-
location mechanism. For penetratin these data support
studies that have reported temperature-dependent up-
take using a similar setup [61,62] but also stand in con-
flict with other studies that used either fixed cells or a
mass spectrometry based approach [10,11]. Still, forma-
tion of vesicles on the outer side of the cell membrane
and in part co-localization with FM4-64 was observed
even at low temperature. When incubating the cells at
37°C co-localization of both peptides with FM4-64 was
observed. FM4-64 has strong affinity towards the plasma
membrane and stains any vesicle that will bud off from
it [63]. Consequently, it is not surprising that individual
red staining can be seen in both cases. For penetratin it
has been shown that its uptake is clathrin-independent
and mainly uses the macropinocytotic route [41,64].
Similarly, Oct4-PTD may also use distinct endocytotic
routes for cellular entry, which remain to be explored.
The nuclear and diffuse cytoplasmic staining also would
suggest that FITC-labelled Oct4-PTD is not only an effi-
cient new CPP but that it is also able to escape the
endosomes, probably by destabilizing the vesicular mem-
brane in a similar fashion as the endosomolytic EB1 pep-
tide [65]. These results lead us to propose the following
model of mechanism of uptake of Oct4-PTD: initial
binding to the membrane and vesicle formation leads to
internalization, mainly driven by endocytosis. After
around 30 min, many vesicles have already entered the
cell and Oct4-PTD starts to distribute into the cytosol
and eventually escapes the endosomes.
Further confirmation that the Oct4-PTD exerts cellu-
lar translocation activity is provided by a Cre/loxP-based
reporter system that has been widely used to study protein
transduction [31,38]. This assay showed weak yet clear b-
Gal staining of reporter cells treated with the wild type
Oct4-PTD-Cre-fusion protein whereas untreated cells
remained unstained. Notably, the Cre-activity of the Oct4-
PTD-fused protein was less pronounced than for the
TAT-PTD. This result indicates that the translocation ac-
tivity of the Oct4-PTD is weaker than that of TAT-PTD at
least in CV1-5B cells.
Finally, we demonstrate that full length human Oct4
was found to enter cells without additional fusion tag
and remained predominantly stuck in vesicles. This ob-
servation correlates well with previously published data
reporting that the majority of the transduced protein
can be detected in perinuclear vesicular structures
[48,49]. From there a subfraction of internalized protein
is able to escape via an endosomal release route that is
not fully understood at molecular level.
In conclusion, we propose that Oct4-PTD might be a
valuable candidate for further investigations concerning its
ability to transport different therapeutic cargo moleculessuch as siRNAs intracellular proteins into cells. Moreover,
our results also suggest that the human Oct4 protein
might be able to actively enter cells via the Oct4-PTD,
further supporting the concept of ‘signalling homeo-
proteins’ found in mammalian but also plant cells [66,67].
Finally, these data support the idea that the addition of a
cationic fusion tag to recombinant Oct4 currently applied
for iPS reprogramming can be avoided. This might con-
tribute to produce integration free induced pluripotent
stem cells [25,27,39].
Additional files
Additional file 1: Table S1. Cre-fusion protein expression vector - oligo
design.
Additional file 2: Figure S2. Purification of Oct4-PTD-Cre fusions. The
estimated size of the given constructs was 42.6 kDa. Annotation of the
nomenclature: L1A: R16A; L2A: K13A/R16A; L4A: wild type Oct4-PTD.
Additional file 3: Figure S3. Cellular proliferation capacity is not
altered by peptides. MTT assay of RPTEC/TERT1 cells after 1 or 24 hours of
incubation with the respective peptides. The bars represent the
endpoints of each measurement at a concentration of 80 μM. 1-way
ANOVA was calculated using Friedmann Test in GraphPad Prism.
Additional file 4: Figure S1. LDr of labelled and unlabelled peptides.
Reduced linear dichroism spectroscopy in the presence of LUVs. Black
lines represent Oct4-PTD, gray lines penetratin either unlabelled (solid) or
labelled (dashed).
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